| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| - | - | 3,200 | ₹4.05 26.56% | 4,50063.63% |
| 5000% | ₹327.35 0% | 3,250 | ₹5.2 -10.34% | 3,00020% |
| 1,2500% | ₹285.7 -0.1% | 3,300 | ₹7.4 -15.42% | 31,00025.25% |
| 1,25025% | ₹245.55 8.86% | 3,350 | ₹10.5 -21.34% | 11,50048.38% |
| 10,5000% | ₹196.45 3.94% | 3,400 | ₹15 -25.37% | 37,75023.77% |
| 7500% | ₹157.2 -3.05% | 3,450 | ₹23 -19.29% | 24,00068.42% |
| 23,5004.44% | ₹117.5 13.41% | 3,500 | ₹33 -25.08% | 43,000-17.30% |
| 44,00011.39% | ₹86 3.61% | 3,550 | ₹50 -24.24% | 23,00091.66% |
| 1,97,50014.49% | ₹61.5 3.53% | 3,600 | ₹73.3 -18.55% | 55,250-7.14% |
| 59,500-11.52% | ₹40.5 -1.57% | 3,650 | ₹107.3 -14.6% | 11,500-4.16% |
| 1,03,75033.44% | ₹27.35 -4.7% | 3,700 | ₹171.85 0% | 4,2500% |
| 19,00035.71% | ₹17.75 -10.57% | 3,750 | ₹182.7 -6.59% | 4,250-29.16% |
| 58,2509.38% | ₹12.6 -4.18% | 3,800 | ₹215.05 0% | 2,0000% |
| 19,000130.30% | ₹8.6 -1.14% | 3,850 | ₹273.25 6.28% | 500100% |
| 34,00054.54% | ₹6.25 -4.58% | 3,900 | ₹340.6 0% | 7500% |
| 1,750133.33% | ₹3.85 148.38% | 3,950 | ₹355.8 0% | 2500% |
| 27,250395.45% | ₹4 6.66% | 4,000 | ₹399 0% | 2500% |
| 500100% | ₹3 0% | 4,100 | - | - |
Torrent Urja, is a wholly owned subsidiary of Torrent Green Energy Pvt. Ltd. The company is incorporated to develop a solar-plus-wind power project.
The transaction involves around 38.75 lakh shares, priced at ₹1,600 each, being offloaded by JB Chemicals employees who recently converted their stock options.
The acquisition values JB Chemicals at ₹25,689 crore on a fully diluted basis, according to the company’s official announcement.
On the operating front, EBITDA for the quarter was reported at ₹964 Crore. It was 9.20% higher than ₹883 in Q4FY24.
Here are some of the stocks that may see significant price movement today: JK Cement, KEC International, Macrotech Developers, etc.
Empagliflozin is a new sodium-glucose co-transporter-2 (SGLT-2) inhibitor approved for glycemic management in individuals with type 2 diabetes.
The USFDA examined Torrent's manufacturing plant in Pithampur during the September quarter and issued a Form 483 with one observation.
The business reported a 13% growth in India revenues to ₹1,632 Crore, driven by outperformance in focus therapies.
When compared to the previous quarter, revenue growth was modest at 1.05%, while net profits experienced a slight decline of 0.88%.
In August, the CDSCO banned more than 156 fixed-dose combination medications from the Indian market.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
